| Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production JA Williams, AE Carnes, CP Hodgson Biotechnology advances 27 (4), 353-370, 2009 | 246 | 2009 |
| Hybridization probe size control: optimized'oligolabelling'. CP Hodgson, RZ Fisk Nucleic acids research 15 (15), 6295, 1987 | 221 | 1987 |
| The vector void in gene therapy CP Hodgson Bio/Technology 13 (3), 222-225, 1995 | 153 | 1995 |
| Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system J Luke, AE Carnes, CP Hodgson, JA Williams Vaccine 27 (46), 6454-6459, 2009 | 125 | 2009 |
| Inducible Escherichia coli fermentation for increased plasmid DNA production AE Carnes, CP Hodgson, JA Williams Biotechnology and applied biochemistry 45 (3), 155-166, 2006 | 120 | 2006 |
| Virosomes: cationic liposomes enhance retroviral transduction CP Hodgson, F Solaiman Nature biotechnology 14 (3), 339-342, 1996 | 120 | 1996 |
| Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine JM Luke, GG Simon, J Söderholm, JS Errett, JT August, M Gale Jr, ... Journal of virology 85 (3), 1370-1383, 2011 | 97 | 2011 |
| Polyadenylylated RNA complementary to a mouse retrovirus-like multigene family is rapidly and specifically induced by epidermal growth factor stimulation of quiescent cells. DN Foster, LJ Schmidt, CP Hodgson, HL Moses, MJ Getz Proceedings of the National Academy of Sciences 79 (23), 7317-7321, 1982 | 94 | 1982 |
| Generic plasmid DNA production platform incorporating low metabolic burden seed‐stock and fed‐batch fermentation processes JA Williams, J Luke, S Langtry, S Anderson, CP Hodgson, AE Carnes Biotechnology and bioengineering 103 (6), 1129-1143, 2009 | 92 | 2009 |
| Vectors for gene-self-assembly C Hodgson US Patent App. 09/836,737, 2002 | 80 | 2002 |
| Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa R Gope, MA Christensen, A Thorson, HT Lynch, T Smyrk, C Hodgson, ... JNCI: Journal of the National Cancer Institute 82 (4), 310-314, 1990 | 80 | 1990 |
| Genomic structure and possible retroviral origin of the chicken CR1 repetitive DNA sequence family. WE Stumph, CP Hodgson, MJ Tsai, BW O'Malley Proceedings of the National Academy of Sciences 81 (21), 6667-6671, 1984 | 75 | 1984 |
| Structure and expression of mouse VL30 genes CP Hodgson, PK Elder, T Ono, DN Foster, MJ Getz Molecular and cellular biology, 1983 | 68 | 1983 |
| Method of gene transfer using retrotransposons CP Hodgson US Patent 5,354,674, 1994 | 66 | 1994 |
| Vectors for gene transfer CP Hodgson US Patent 6,027,722, 2000 | 61 | 2000 |
| DNA dose and sequence dependence in sperm‐mediated gene transfer I Sciamanna, S Piccoli, L Barberi, G Zaccagnini, AR Magnano, ... Molecular Reproduction and Development: Incorporating Gamete Research 56 (S2 …, 2000 | 53 | 2000 |
| Efficient packaging of a specific VL30 retroelement by Ψ2 cells which produce MoMLV recombinant retroviruses M Hatzoglou, CP Hodgson, F Mularo, RW Hanson Human Gene Therapy 1 (4), 385-397, 1990 | 53 | 1990 |
| Patent Update: Biologicals & Immunologicals: Advances in vector systems for gene therapy CP Hodgson Expert Opinion on Therapeutic Patents 5 (5), 459-468, 1995 | 51 | 1995 |
| RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines1 AA Ali, JN Marcus, JP Harvey, R Roll, CP Hodgson, DM Wildr1Ck, ... The FASEB journal 7 (10), 931-937, 1993 | 51 | 1993 |
| Plasmid DNA fermentation strain and process‐specific effects on vector yield, quality, and transgene expression AE Carnes, JM Luke, JM Vincent, A Schukar, S Anderson, CP Hodgson, ... Biotechnology and bioengineering 108 (2), 354-363, 2011 | 49 | 2011 |
